Evidence map›Paper›PMID 41876500›Full record

ArticleNature communications2026

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

Majd Abdallah, Sigve Nakken, Mikaël Georges, Mariska Bierkens, Johanna Galvis, Alexis Groppi, Slim Karkar, Lana Meiqari, Maria Alexandra Rujano, Steve Canham and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. AI for clinical trials in oncology.ESMO real world data and digital oncology · 2026
    Review
  8. State of clinical AI in 2026.BMJ digital health & AI · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Majd AbdallahUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France. abdallahmajd7@gmail.com.ORCID http://orcid.org/0000-0002-8371-1793
Sigve NakkenDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8468-2050
Mikaël GeorgesUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France.
Mariska BierkensDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Johanna GalvisUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France.ORCID http://orcid.org/0000-0001-9852-3798
Alexis GroppiUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France.ORCID http://orcid.org/0000-0002-3341-8281
Slim KarkarUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France.
Lana MeiqariDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9348-4830
Maria Alexandra RujanoEuropean Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, Paris, France.
Steve CanhamEuropean Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, Paris, France.
Rodrigo DienstmannOncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Remond FijnemanDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2076-5521
Eivind HovigDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-9103-1077
Gerrit MeijerDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0330-3130
Macha NikolskiUniversity of Bordeaux, CNRS, IBGC UMR 5095, Bordeaux, France. macha.nikolski@u-bordeaux.fr.ORCID http://orcid.org/0000-0001-6059-577X

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101058427
6 · The paper itself

Abstract

Patient recruitment remains a major bottleneck in clinical trials, calling for scalable and automated solutions. We present TrialMatchAI, an AI-powered recommendation system that automates patient-to-trial matching by processing heterogeneous clinical data, including structured records and unstructured physician notes. Built on fine-tuned, open-source large language models (LLMs) within a retrieval-augmented generation framework, TrialMatchAI ensures transparency and reproducibility and maintains a lightweight deployment footprint suitable for clinical environments. The system normalizes biomedical entities, retrieves relevant trials using a hybrid search strategy combining lexical and semantic similarity, re-ranks results, and performs criterion-level eligibility assessments using medical Chain-of-Thought reasoning. This pipeline delivers explainable outputs with traceable decision rationales. In real-world validation, 92% of oncology patients had at least one relevant trial retrieved within the top 20 recommendations. Evaluation across synthetic and real clinical datasets confirmed state-of-the-art performance, with expert assessment validating over 90% accuracy in criterion-level eligibility classification - particularly excelling in biomarker-driven matches. Designed for modularity and privacy, TrialMatchAI supports Phenopackets-standardized data, enables secure local deployment, and allows seamless replacement of LLM components as more advanced models emerge. By enhancing efficiency, interpretability and offering lightweight, open-source deployment, TrialMatchAI provides a scalable solution for AI-driven clinical trial matching in precision medicine.

Indexed as

Artificial IntelligenceClinical Trials as TopicPatient SelectionHumansIntelligent SystemsLarge Language ModelsReproducibility of Results

Identifiers

PMID41876500
PMCPMC13187043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.